Xconomy | Kendall Square -
Business + Technology in the Exponential Economy

Codon Devices “Streamlines” Operation, To Focus on Synthetic Biology
Repligen, BMS Settle Patent Suit
Codon Signs Partnership to Develop Biofuels From Algae
EMC Tangos with Conchango, MIT Media Lab Goes to the Bank, GT Solar Makes European Inroads, & More Deals News
Glaxo Wins Round One in Lawsuit Against the U.S. Patent Office—Early Victory for Biotech and Pharma

Codon Devices Settles Patent Suit

Synthetic biology startup Codon Devices of Cambridge, MA, announced today that it has reached a settlement with Blue Heron Biotechnology of Bothell, WA, in a patent suit that Codon filed against the Washington firm last March. The suit involved five patents that were exclusively licensed to Codon—one from MIT and four from Duke University. As part of the agreement, financial terms of which were not disclosed, Codon has granted Blue Heron a sublicense on the technology.

Permalink |